Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repros Therapeutics Inc (NASDAQ:RPRX)

0.6635
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
0.26
Today|||52-Week Range
1.55
-49.73%
Year-to-Date

Today’s Trading

Previous close0.66
Today’s open0.67
Day’s range0.66 - 0.67
Volume1,390,298
Average volume (3 months)1,119,174
Market cap$26.2M
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)+41.67%
Earnings growth (this year)-52.86%
Earnings growth (next 5 years)+27.95%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.81

Competitors

 Today’s
change
Today’s
% change
SBOTStellar Biotechnolog...0.000.00%
EVARFLombard Medical Inc0.000.00%
ARGSArgos Therapeutics I...0.000.00%
HEBHemispherx Biopharma...0.000.00%
Data as of 8:00pm ET, 12/15/2017

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$0.00
Annual profit (last year)-$17.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Larry M. Dillaha
CFO, Secretary &
Principal Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts